Rising Prevalence Of Long-Term Diseases And Comorbidities Fueling Growth In The Contrast Media Market: Critical Driver Shaping the Contrast Media Market in 2025

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

Contrast Media Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The size of the contrast media market has seen consistent expansion over the recent years. The market worth is predicted to rise from $4.68 billion in 2024 to $4.89 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 4.3%. The historical growth has been driven by factors such as the growing need for healthcare due to an aging population, advances in radiology and imaging centers, a surge in minimally invasive procedures, an increasing number of cardiovascular diseases, and the global spread of healthcare services.

Contrast Media Market Size Forecast: What's the Projected Valuation by 2029?
The market size of contrast media is predicted to witness robust expansion in the forthcoming years, reaching a value of $6.02 billion in 2029, with a Compound Annual Growth Rate (CAGR) of 5.4%. The forecasted surge during this period could be attributed to the rise of molecular imaging, the broadening of diagnostic imaging techniques, personalized medical practices, the global affliction of cancer, the expanding uses in neuroimaging, and the shift towards outpatient imaging services. In the forecast period, major trends incorporate advancements in imaging technologies, an emphasis on patient safety and reduced nephrotoxicity, increased use in interventional radiology, growing applications in cancer imaging, the debut of low-osmolality contrast media, and the adoption of microbubbles in ultrasound imaging.

View the full report here:
https://www.thebusinessresearchcompany.com/report/contrast-media-global-market-report

What Are the Drivers Transforming the Contrast Media Market?
The surging incidence of chronic illnesses and complicated comorbidities is anticipated to catalyze expansion in the contrast media market. Comorbidity describes the concurrent presence of multiple diseases in an individual. A contrast medium (CM) is a technique utilized in imaging to highlight the differences between human tissues in images. The ideal contrast medium results in exceedingly high concentrations in tissues without producing any adverse effects, thereby boosting its demand. An example from May 2022 indicates, as per data from Oxford Academic, a university press affiliated with the University of Oxford in the UK, the prevalence of 2 or more comorbidities was greater prior to the age of 65 in individuals with Intellectual disabilities (ID). However, the highest prevalence post age 65 was seen in individuals without ID. The largest spike in instances of 2 or more comorbidities in those with ID or Chronic Obstructive Pulmonary Disease (COPD) was seen between the ages of 55-59. Furthermore, 17.6% of people with ID and Cardiovascular Disease (CVD) were 60-64 years old and had 2 or more comorbid conditions. Consequently, the escalating prevalence of enduring diseases and intricate comorbidities propels the contrast media market's growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7991&type=smp

What Long-Term Trends Will Define the Future of the Contrast Media Market?
Advancements in technology are increasingly gaining momentum as a noticeable trend within the contrast media market. This trend is particularly prevalent among dominant players in the field who aim to solidify their status through the introduction of innovative technological solutions. For example, in June 2022, Bayer, a global company based in Germany with a substantial presence in the contrast media market, unveiled Calantic Digital Solutions. This novel platform offers access to a multitude of digital applications, included but not limited to AI-enabled programs specifically tailored for medical imaging, fostering enhanced lesion detection, evaluation, quantification, and productivity among radiology teams. Furthermore, this platform equips healthcare professionals with the necessary tools to navigate every stage of their professional practice, from the initial diagnosis phase to the treatment of patients.

Which Segments in the Contrast Media Market Offer the Most Profit Potential?
The contrast media market covered in this report is segmented -

1) By Type: Barium-Based Contrast Media, Iodinated Contrast Media, Gadolinium-Based Contrast Media, Microbubble Contrast Media
2) By Route Of Administration: Intravascular Route, Oral Route, Rectal Route, Other Route Of Administration
3) By Modality: X-Ray Or CT, MRI, Ultrasound
4) By Indication: Cardiovascular Disease, Oncology, Gastrointestinal Disorders, Neurological Disorders, Other Indications
5) By End User: Hospitals, Clinics

Subsegments:
1) By Barium-Based Contrast Media: Barium Sulfate Suspensions, Barium Tablets
2) By Iodinated Contrast Media: Non-Ionic Iodinated Contrast Media, Ionic Iodinated Contrast Media
3) By Gadolinium-Based Contrast Media: Macrocyclic Gadolinium Agents, Linear Gadolinium Agents
4) By Microbubble Contrast Media: Ultrasound Contrast Agents, Other Microbubble Formulations

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=7991&type=smp

Which Firms Dominate the Contrast Media Market by Market Share and Revenue in 2025?
Major companies operating in the contrast media market are Bayer AG, GE Healthcare, Guerbet Group, Lantheus Medical Imaging Inc., Unijules Life Sciences Ltd., J. B Chemicals and Pharmaceutical Ltd., Trivitron Healthcare Pvt. Ltd., Taejoon Pharm Co Ltd., Nano Therapeutics Pvt. Ltd., iMax Diagnostic Imaging Limited, Jodas Expoim Pvt Ltd., Livealth Biopharma Pvt. Ltd., SANOCHEMIA Pharmazeutika GmbH, Kiran Medical Systems Limited, Unispire Biopharma Private Limited, Daiichi Sankyo Company Limited, Bracco Diagnostics Inc., Jiangsu Hengrui Medicine Co. Ltd., Shanghai Xudong Haipu Pharmaceutical Co. Ltd., Spago Imaging AB, Curium Inc., Poly Pharmaceutical Co. Ltd., Zhejiang Starry Pharmaceutical Co. Ltd., Yangtze River Pharmaceutical Group, Wuhan Grand Hoyo Co. Ltd., China Resources Zizhu Pharmaceutical Co. Ltd., AMAG Pharmaceuticals Inc., Guerbet LLC

Which Regions Offer the Highest Growth Potential in the Contrast Media Market?
North America was the largest region in the contrast media market in 2024. Asia-Pacific is expected to be the fastest-growing region in the contrast media market report during the forecast period. The regions covered in the contrast media market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7991

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.